by Sam Eskandari | Aug 28, 2019 | News
VANCOUVER, British Columbia, August 28, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”). Further to the Company’s news release of November 14, 2018, the sale of the Company’s 100% interest in Sechelt Organic...
by Sam Eskandari | Aug 23, 2019 | News
VANCOUVER, British Columbia, July 23, 2019 — Veritas Pharma Puerto Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce that it has reached a settlement with Arbutus Biopharma Corporation (“Arbutus”) with respect to the litigation...
by Sam Eskandari | May 15, 2019 | News
VANCOUVER, British Columbia, May 15, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has undertaken steps to restructure and rebuild Cannevert Therapeutics Ltd. (“CTL”), a wholly owned...
by Sam Eskandari | May 15, 2019 | News
SAN JUAN, Puerto Rico, May 15, 2019 — Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce the completion of its clinical trial on its lead cannabis...
by Sam Eskandari | Mar 27, 2019 | News
VANCOUVER, British Columbia, March 27, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce corporate highlights and to communicate the company’s direction for the year ahead. 2018 and the...
